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EndocarditisAbstract Paravalvular leak occurs in 1–5% patients following surgical valve replacement and is
associated with complications including haemolysis, heart failure and endocarditis. Re-do surgery
is difficult with mortality rates approaching 16%. Percutaneous closure of mitral valve leaks with
occluder devices is a viable alternative to repeat sternotomy; however, clinicians should be aware
of contra-indications which include active endocarditis. Management of paravalvular leak is com-
plex and success requires multi-disciplinary approach with cardiothoracic surgeons, clinical, imag-
ing and interventional cardiologists.
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and marked exertional dyspnoea (NYHA class III). He had
underwent mitral valve replacement the previous year for sev-
ere mitral regurgitation with a size 33 mm CarboMedics pros-
thesis. In childhood he had undergone surgical repair of a
secundum atrial septal defect.
On examination he was haemodynamically stable and in
controlled atrial fibrillation. Auscultation revealed a prosthetic
first heart sound and a normal second heart sound, and a
grade 2/6 pansystolic murmur with a grade 1/6 diastolic mur-
mur. The patient was euvolaemic and with a normal respira-
tory system examination.
Chest radiograph demonstrated cardiomegaly but no pul-
monary venous congestion. Electrocardiogram confirmed con-
trolled atrial fibrillation. C-reactive protein was elevated at
60 mg/L although he was not overtly septic. Bilirubin was33 lmol/l and haemoglobin concentration of 109 g/L so valvu-
lar haemolysis was considered.
During the admission the patient became febrile. Multiple
blood cultures grew a methicillin sensitive staphyloccus aureus.
The patient proceeded to transoesophageal echocardiography
(TOE) which confirmed a small vegetation on the sewing ring
but also demonstrated significant paravalvular regurgitation.
Live 3-D reconstruction allowed the exact size and shape of
the leak to be identified as percutaneous approach to par-
avalvular leak closure was being considered. After multiple
multidisciplinary team discussion, the consensus was for a sur-
gical approach to paravalvular leak closure given the recent
history of endocarditis. This would also facilitate surgical valve
replacement at the time, should it be required (see Figs. 1–3).
Paravalvular leak occurs in 1–5% patients following surgi-
cal valve replacement and is associated with complications
including haemolysis, heart failure and endocarditis.1 Par-
avalvular leak is more likely to occur early following valve
replacement, while longer term paravalvular leaks can occur
in the setting of endocarditis. Re-do surgery is difficult with
mortality rates approaching 16%.2,3 Percutaneous closure of
Figures 1–3 1. Colour Doppler TOE view of the mechanical mitral valve at 0. 2. TOE 3-D live reconstruction of the mitral valve.
3. TOE 3-D reconstruction delineating size and position of paravalvular leak.
282 C. McQuillan, J. Tweediemitral valve leaks with occluder devices is a viable alternative
to repeat sternotomy; however, clinicians should be aware of
contra-indications which include active endocarditis.4
Management of paravalvular leak is complex and success
requires multi-disciplinary approach with cardiothoracic
surgeons, clinical, imaging and interventional cardiologists.5
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